CAM
RMD icon

ClariVest Asset Management’s ResMed RMD Stock Holding History

ClariVest Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$766 Hold
4
– – ﹤0.01% 686
2024
Q2 		$766 Hold
4
– – ﹤0.01% 686
2024
Q1 		$785 Hold
4
– – ﹤0.01% 710
2023
Q4 		$692 Sell
4
-8
-67% -$1.23K ﹤0.01% 746
2023
Q3 		$1K Buy
12
+3
+33% +$542 ﹤0.01% 709
2023
Q2 		$2K Buy
9
+6
+200% +$1.34K ﹤0.01% 545
2023
Q1 		$1K Buy
+3
New +$651 ﹤0.01% 689

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

ClariVest Asset Management's RMD Position: Q3 2024 in Review

ClariVest Asset Management held its ResMed (RMD) position steady in Q3 2024 at 4 shares worth $766. The position accounts for ﹤0.01% of the portfolio, ranked #686.

ClariVest Asset Management first reported a position in RMD in Q1 2023 and has held it in 7 quarters since. The position peaked at $2K in Q2 2023. 802 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • ClariVest Asset Management held 4 shares of ResMed worth $766 as of Q3 2024.
  • ClariVest Asset Management left its ResMed share count unchanged in Q3 2024.
  • ResMed made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #686 holding.
  • ClariVest Asset Management first reported a position in ResMed in Q1 2023 and has held it in 7 quarters since.
  • ClariVest Asset Management's ResMed position peaked at $2K in Q2 2023.
  • 802 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.